Stay informed with the latest litigation news. Explore now

Use Of Aminopyridine, In Particular Amirampridine, In The Treatment Of Virally Associated Fatigue - EP4349333B1

EP4349333

BHMEKE
Application Number
EP23188553A
Filing Date
Jul 28, 2023
Status
Granted And Under Opposition
Sep 27, 2024
Grant Date
Oct 30, 2024
External Links
Slate, Register, Google Patents

Bibliography

The patent EP4349333B1 was granted to Bhmeke on Oct 30, 2024 following the initial filing on Jul 28, 2023 under the application number EP23188553A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

LANGEJul 29, 2025ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents